SIBN
SI-BONE·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 1
Bearish signal 2
Consensus Rating "Strong Buy"
Price Hits 52-week Low
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SIBN
Si-Bone, Inc.
A developer of proprietary minimally invasive surgical implant system to treat sacroiliac joint dysfunction
Healthcare Equipment and Supplies
03/18/2008
10/17/2018
NASDAQ Stock Exchange
349
12-31
Common stock
471 El Camino Real, Suite 101, Santa Clara, California 95050
--
SI-BONE, Inc., was incorporated in Delaware on March 18, 2008 and is headquartered in Santa Clara, California. The company is a medical device company that addresses musculoskeletal diseases in sacropelvic anatomy. Leveraging knowledge of pelvic anatomy and biomechanics, the company has pioneered proprietary minimally invasive surgical implant systems to address sacroiliac joint dysfunction and address unmet clinical needs in pelvic fusion, fixation and pelvic fracture management. The company's products include a range of patented titanium implants and devices for implanting them. Since the launch of the first generation iFuse in 2009, the company has launched three new implant product lines, iFuse-3D in 2017, iFuse-TORQ in 2021 and iFuse Bedrock Granite in 2022. In the United States, the company's iFuse, iFuse-3D and iFuse-TORQ implant systems are licensed for use in sacroiliac joint dysfunction and fusion, adult deformities and degeneration, and pelvic trauma.
Earnings Call
Q2/2025
Estimate EPS-0.18
Actual EPS-0.14
Estimate Revenue48.12M
Actual Revenue48.60M
SI-BONE's Q2 2025: Navigating Contradictions in Growth Strategy and Margin Guidance
Aug 05,2025 01:57
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
SIBN has released its 2025 Q3 earnings. EPS was reported at -0.11, versus the expected -0.17, beating expectations. The chart below visualizes how SIBN has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
SIBN has released its 2025 Q3 earnings report, with revenue of 48.66M, reflecting a YoY change of 20.61%, and net profit of -4.57M, showing a YoY change of 30.56%. The Sankey diagram below clearly presents SIBN's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
